Addendum of Newer Anticoagulants to the SIR Consensus Guideline

Patel, Indravadan; Davidson, J.; Nikolic, Boris; Salazar, Gloria M.; Schwartzberg, Marc S.; Walker, T.G.; Saad, Wael E.A.

doi:10.1016/j.jvir.2012.12.007

Cited by 108 publications

(58 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…SIR anticoagulation consensus guidelines were followed (8,9). This includes patients having a platelet count of > 50 × 10 9 /L and international normalized ratio of < 1.5 before any solid organ biopsy.…”

Section: Methodsmentioning

confidence: 99%

“…However, Burger et al (7) reported a 50% increase in bleeding complications related to periprocedural aspirin use and concluded that aspirin discontinuation should be considered before any biopsy or surgery. Current Society of Interventional Radiology (SIR) guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions recommend withholding aspirin for 5 days before procedures with significant bleeding risk (8,9). This recommendation is based on the approximate 10-day life span of platelets, such that with aspirin therapy cessation for 5 days, the pool of functional platelets would be approximately 30%–50% (8).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Effects of Aspirin Therapy on Ultrasound–Guided Renal Allograft Biopsy Bleeding Complications

Baffour¹,

Hickson²,

Stegall³

et al. 2017

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

Purpose To determine if patient aspirin exposure and timing affect bleeding risk after renal allograft biopsy. Materials and Methods Review of 6,700 renal allograft biopsies (in 2,362 unique patients) was performed. Median patient age was 53.0 years [interquartile range 43.0, 62.0]; 56.2% of patients were male. Of biopsies, 4,706 (70.2%) were performed in patients with no aspirin exposure within 10 days of biopsy; 664 (9.9%), were performed within 8–10 days of aspirin exposure; 855 (12.8%), within 4–7 days; and 475 (7.1%), within 0–3 days. Follow-up to 3 months after the procedure was completed in all patients. Biopsies were categorized as protocol or indication; 19.7% were indication biopsies. Bleeding complications were graded based on SIR criteria. Logistic regression models examined the association between aspirin use and bleeding events. Results Rate [95% confidence interval] of major bleeding complications was 0.24% [0.14, 0.39], and rate of any bleeding complication was 0.66% [0.46, 0.90]. Bleeding events were significantly associated with patients undergoing indication biopsies compared with protocol biopsies (odds ratio [OR] 2.27, P = .012). Patient factors associated with major bleeding complications in multivariate models included estimated glomerular filtration rate (OR 0.61, P = .016) and platelet count (OR 0.64, P = .033). Aspirin use was not significantly associated with increased risk of bleeding complication except for use of 325 mg of aspirin within 3 days of biopsy (any complication OR 3.87 [1.12, 13.4], P = .032; major complication OR 6.30 [1.27, 31.3], P = .024). Conclusions Renal allograft biopsy bleeding complications are very rare, particularly for protocol biopsies. Use of 325 mg of aspirin within 3 days of renal allograft biopsy was associated with increased bleeding complications.

show abstract

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

Effects of Aspirin Therapy on Ultrasound–Guided Renal Allograft Biopsy Bleeding Complications

Baffour¹,

Hickson²,

Stegall³

et al. 2017

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

show abstract

“…The Society of Interventional Radiology has published a consensus recommending an acceptable level for coagulation parameters based on the procedure to be performed. 3 …”

Section: Laboratory Datamentioning

confidence: 99%

Optimizing Common Femoral Artery Access

Rajebi

2015

Techniques in Vascular and Interventional Radiology

View full text Add to dashboard Cite

“…To address this complex issue, the Society of Interventional Radiology in conjunction with the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has previously produced guidelines based on existing evidence and expert consensus on periprocedural haematological management for image-guided procedures which are stratified into three categories according to the bleeding risk (Table 1). 4 However, despite the existence of such guidelines, from our experience, significant variation in practice exists between clinicians, even within our own institution.…”

mentioning

confidence: 94%

“…For example, in two separate internationally accepted guidelines, the recommended international normalized ratio (INR) for chest drain insertion is ,1.5 and ,2.0. 3,4 There is also limited scope to transfer existing evidence on haematological management from other domains such as open surgery to image-guided interventions. Unlike conventional open surgical procedures where bleeding may be visualized immediately and controlled by direct pressure or vessel ligation, bleeding from imageguided procedures may be difficult to control owing to issues with access and identification.…”

mentioning

confidence: 99%

Current practice of periprocedural haematological management for patients undergoing image-guided procedures

Tun

Khwaja²,

Flanagan³

et al. 2015

BJR

View full text Add to dashboard Cite

Objective: To evaluate current UK practice of periprocedural haematological management for image-guided procedures in relation to Cardiovascular and Interventional Radiological Society guidelines, which provide recommendations according to bleeding risk of procedures from Category 1 (lowest) to 3 (highest). Methods: Survey of practice in UK radiology departments conducted over a 1-year period Results: 48 radiology departments responded. The percentage of departments that stop antithrombotics preprocedurally are as follows (for Category 1, 2 and 3, respectively): aspirin (31.3%, 43.8%, 54.2%); clopidogrel (54.2%, 68.8%, 72.9%); therapeutic low-molecular-weight heparin (56.3%, 77.1%, 75.0%). The percentage of departments that perform pre-procedural laboratory testing are as follows (for Category 1, 2 and 3, respectively): international normalized ratio (INR; 81.3%, 95.8%, 93.8%); activated partial thrombin time ratio (APTTR; 60.4%, 75.0%, 93.8%); platelet (77.1%, 91.7%, 95.7%); haemoglobin (70.8%, 85.4%, 87.5%). Mean threshold (standard deviation) of laboratory results for conducting procedures (Level 1, 2 and 3, respectively) are as follows: INR

show abstract

Addendum of Newer Anticoagulants to the SIR Consensus Guideline

Cited by 108 publications

References 11 publications

Effects of Aspirin Therapy on Ultrasound–Guided Renal Allograft Biopsy Bleeding Complications

Effects of Aspirin Therapy on Ultrasound–Guided Renal Allograft Biopsy Bleeding Complications

Optimizing Common Femoral Artery Access

Current practice of periprocedural haematological management for patients undergoing image-guided procedures

Contact Info

Product

Resources

About